ArticleJCO precision oncology2022

Changes in Circulating Tumor DNA Reflect Clinical Benefit Across Multiple Studies of Patients With Non-Small-Cell Lung Cancer Treated With Immune Checkpoint Inhibitors.

Diana Merino Vega et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.